Literature DB >> 15927337

Possible malignant neuroleptic syndrome that associated with hypothyroidism.

Cagatay Taskapan1, Ibrahim Sahin, Hulya Taskapan, Burhanettin Kaya, Feridun Kosar.   

Abstract

A 54-year-old woman with schizophrenia presented to hospital with unconsciousness, fever and marked muscle rigidity. She had been given fluphenazine decanoete 20 mg intramuscularly 15 days before the admission and she had continued taking haloperidol 20 mg daily and oral biperiden 2-4 mg. She was extremely rigid and unresponsive. On laboratory investigations revealed: serum sodium 120 mEq/l, creatinine phosphokinase 12,980 IU/l (normal up to 170), lactate dehydrogenase 1544 IU/l (150-500), free trioidothyronine < 1.00 pg/ml (1.5-4.5), free throxyine 0.76 ng/dl (0.8-1.9), thyroid stimulating hormone 1.14 microU/ml (0.4-4), cortisol (at 8.00 a.m.) 9 microg/dl (5-25). Antipsychotic drugs were withdrawn after admission. A diagnosis of secondary adrenal insufficiency and secondary hypothyroidism was made. Hormonal substitution with hydrocortisone and levothyroxine and correction of hyponatremia with intravenous hypertonic saline solution resulted in rapid improvement of symptoms and signs. It seems that the symptoms and signs of hypothyroidism and hyponatremia were attributed to acute psychosis in this patient. As a conclusion failure to recognize the endocrinopathy may not only produce recovery difficulties but also psychiatric and endocrine repercussions if psychotropic medications are given in such masked cases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15927337     DOI: 10.1016/j.pnpbp.2005.04.004

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  3 in total

Review 1.  Antipsychotic-induced hyponatraemia: a systematic review of the published evidence.

Authors:  Didier Meulendijks; Cyndie K Mannesse; Paul A F Jansen; Rob J van Marum; Toine C G Egberts
Journal:  Drug Saf       Date:  2010-02-01       Impact factor: 5.606

2.  Neuroleptic malignant syndrome with thyroid disorder: An unusual case report.

Authors:  Fan Zhang; Parisa Kanzali; Vadim Rubin; Chris Paras; Joel Goldman
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

3.  Case Report: A Patient With Neuroleptic Malignant Syndrome, Water Intoxication and Hyponatremia Associated With Severe Cerebral Edema and Coma.

Authors:  Haruka Takenouchi; Takatoshi Anno; Yukiko Kimura; Fumiko Kawasaki; Ryo Shirai; Hideaki Kaneto; Katsumi Kurokawa; Koichi Tomoda
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-10       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.